Related to Resequencing Still Being Targeted

• Human Genome Redux: Just a Numbers Game?
  Success of sequencing capabilities is dependent on tools to analyze the data.
  
• The $1,000 Genome: From Laboratory to Lifestyle
  How we resolve current issues with genetic testing will shape consumer genomics.
  
• Patient Privacy or Scientific Advances: Do They Have to Be Mutually Exclusive?
  Presidential Commission weighs pros and cons of making sequencing data available to researchers and patients.
  
• Why Biomarker Discovery Is Hard
  Differentiating which markers are in the driver’s seat and which are along for the ride is key.
  
• Are You Already Obsolete?
  To stay ahead in the ever-quickening world of research, scientists must be fast and cunning.
  
• One Small Step, No Giant Leap for Privacy
  Privacy and Progress in Whole-Genome Sequencing report lacks implementation framework.
  
• The Long and the Short of DNA Sequencing
  Third-generation sequencers improve on second-generation systems by offering longer reads.
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Arrivederci, GINA
  New rules on protecting genetic privacy are under way, as study rekindles debate over sharing vs. protecting data.
  
• Detecting Acquired Drug Resistance in Cancer
  New methods allow noninvasive analysis in blood plasma.
  
• Your Genes, Your Choice?
  Critics say the American College of Medical Genetics and Genomics’ recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy.
  
• Moving Genomics Closer to the Clinic
  Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.